DELTAPAQ CERECYTE CDF100515-30Recalls & reported problems
Medos International Sàrl · DELTAPAQ microcoil DELTAPAQ 10 CERECYTE Coil 5mm x 15cm 190cm Contents: 1 Detachable Coil System · Class 2 · Implant
All models of DELTAPAQ CERECYTE (20)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00878528007302), received between Jun 19, 2017 and May 7, 2019 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Stretched” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Stretched2
- Difficult To Position1
- Difficult or Delayed Activation1
- Premature Activation1
Patient problems
- No Consequences Or Impact To Patient3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 7, 2019Stretched; Difficult or Delayed Activation; Stretched; Difficult or Delayed Activation
THE HEALTHCARE PROFESSIONAL REPORTED THAT DURING THE COIL EMBOLIZATION PROCEDURE, AFTER THE FIRST COIL CHOSEN TO START THE PROCEDURE, THE 3 MM X 10 CM DELTAPAQ 10 CERECYTE COIL (CDF10031030 / C35111) ENCOUNTERED DIFFICULTY WITH BEING COMPLETELY DEPLOYED FROM THE MICROCATHETER, IT WAS REPLACED WITH THE 5MM X 15CM DELTAPAQ 10 CERECYTE COIL (CDF10051530 / S14517), AND THE SAME ISSUE OCCURRED; THE COIL COULD NOT BE COMPLETELY DEPLOYED FROM THE MICROCATHETER. THERE WAS NO REPORT OF ANY PATIENT INJURY OR COMPLICATION. THE PRODUCTS ARE AVAILABLE TO BE RETURNED FOR EVALUATION.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8588427 ↗MalfunctionApr 27, 2018Premature Activation; Premature Activation
AS REPORTED BY A HEALTHCARE PROFESSIONAL, A TOTAL OF THREE THERMO-MECHANICAL COILS, ONE 3MM X 6CM DELTAPAQ (CDF10030630/UNK LOT), ONE 3MM X 8CM DELTAPAQ (CDF10030830/UNK LOT), AND ONE 5MM X 15CM DELTAPAQ (CDF10051530/UNK LOT), FAILED TO RE-SHEATH DURING THE PROCEDURE. THE COILS WERE REPLACED AND THE PROCEDURE WAS COMPLETED SUCCESSFULLY. THERE WAS NO REPORT OF CONSEQUENCE OR IMPACT TO THE PATIENT. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7468205 ↗MalfunctionJun 19, 2017Difficult To Position; Stretched; Difficult To Position; Stretched
AS REPORTED BY A HEALTHCARE PROFESSIONAL, DURING THE PROCEDURE, THE DELTAPAQ COIL (CDF10051530/ C39413) COULD NOT BE INSERTED INTO THE ANEURYSM DUE TO POSITIONING DIFFICULTY AND STRETCHED. THEY WITHDREW THE COIL WITHOUT DIFFICULTY, AND USED A NEW COIL TO COMPLETE THE PROCEDURE. THERE HAD BEEN NO RESISTANCE BETWEEN THE DELTAPAQ AND THE MICROCATHETER, AND A CONTINUOUS FLUSH HAD BEEN MAINTAINED THROUGH THE MICROCATHETER. ANEURYSM CHARACTERISTICS AND SIZE WERE UNAVAILABLE. THERE WAS NO REPORT OF PATIENT INJURY OR PROCEDURE DELAY. IT WAS REPORTED THAT THE DEVICE WOULD BE RETURNED FOR ANALYSIS.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6650488 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page